Anatomic Lung Resection After Neoadjuvant Chemoimmunotherapy

Friday, September 27, 2024

2:30 PM – 3:00 PM East Coast USA Time

Location: Del Lago 1&2, Lower Level

CE: .5

Member Speaker(s)

PB

Peter Baik, DO, FACOS, FACS

Thoracic Surgeon
City of Hope Phoenix
City of Hope

Slides

Disclosure(s):

Peter Baik, DO, FACOS, FACS: Astra Zeneca: Board Member/Advisory Panel (Ongoing), Speaker Bureau (Ongoing); FlexPerc: Board Member/Advisory Panel (Ongoing)

Learning Objectives:

Describe the role of immunotherapy in Non-Small Cell Lung cancer
Describe the surgical outcomes after neoadjuvant chemo-immunotherapy
Describe the potential challenges encountered after neoadjuvant chemo-immunotherapy